FDMT
4D Molecular Therapeutics, Inc.Company with tickers: FDMT
CIK
1650648
CUSIP
35104E100
Shares Outstanding
52,276,254
13F Activity (30d)
109 filings
104 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2021-06-07 | Zimmermann Carolyne |
Chief Business Officer | Other | 0 |
| 2021-09-27 | SCHAFFER DAVID |
Director | Sell | 6,157 |
| 2021-09-27 | SCHAFFER DAVID |
Director | Sell | 100 |
| 2021-09-27 | SCHAFFER DAVID |
Director | Sell | 13,075 |
| 2021-09-28 | SCHAFFER DAVID |
Director | Sell | 13,812 |
| 2021-09-28 | SCHAFFER DAVID |
Director | Sell | 100 |
| 2021-09-29 | SCHAFFER DAVID |
Director | Sell | 7,806 |
| 2021-09-29 | SCHAFFER DAVID |
Director | Sell | 700 |
| 2021-09-29 | SCHAFFER DAVID |
Director | Sell | 8,365 |
| 2021-09-30 | SCHAFFER DAVID |
Director | Sell | 4,549 |
| 2021-09-30 | SCHAFFER DAVID |
Director | Sell | 7,836 |
| 2021-10-20 | SCHAFFER DAVID |
Director | Sell | 11,565 |
| 2021-10-21 | SCHAFFER DAVID |
Director | Sell | 22,820 |
| 2021-10-22 | SCHAFFER DAVID |
Director | Sell | 1,900 |
| 2022-02-01 | Moretti August J |
Chief Financial Officer | Other | 2,000 |
| 2022-02-01 | Moretti August J |
Chief Financial Officer | Award | 65,000 |
| 2022-02-01 | FISHMAN ROBERT S |
Chief Medical Officer | Award | 65,000 |
| 2022-02-01 | Zimmermann Carolyne |
Chief Business Officer | Award | 35,000 |
| 2022-02-01 | Kirn David |
Director, Chief Executive Officer | Award | 150,000 |
| 2022-02-01 | Kamal Fariborz |
President & COO | Award | 70,000 |
| 2022-02-01 | Kirn David |
Director, Chief Executive Officer | Other | 2,000,000 |
| 2022-03-21 | Bizily Scott |
Chief Legal Officer | Other | 0 |
| 2022-03-21 | Bizily Scott |
Chief Legal Officer | Other | 0 |
| 2022-05-23 | Miller-Rich Nancy |
Director | Award | 22,500 |
| 2022-05-23 | Chacko Jacob |
Director | Award | 22,500 |
| 2022-05-23 | MILLIGAN JOHN F |
Director | Award | 33,750 |
| 2022-05-23 | THEUER CHARLES |
Director | Award | 22,500 |
| 2022-05-23 | Tomasello Shawn |
Director | Award | 22,500 |
| 2022-05-23 | GRAY SUSANNAH |
Director | Award | 22,500 |
| 2022-06-16 | BVF PARTNERS L P/IL |
10% Owner | Other | 209,716 |
| 2022-06-16 | BVF PARTNERS L P/IL |
10% Owner | Other | 1,570,857 |
| 2022-06-16 | BVF PARTNERS L P/IL |
10% Owner | Other | 2,132,411 |
| 2022-06-18 | Bizily Scott |
Chief Legal Officer | Award | 24,000 |
| 2022-09-01 | Moretti August J |
Chief Financial Officer | Other | 2,000 |
| 2022-09-01 | Bizily Scott |
Chief Legal Officer | Award | 60,000 |
| 2022-09-01 | Kamal Fariborz |
President & COO | Award | 60,000 |
| 2022-09-01 | Moretti August J |
Chief Financial Officer | Award | 60,000 |
| 2022-09-01 | FISHMAN ROBERT S |
Chief Medical Officer | Award | 60,000 |
| 2022-09-23 | Kasahara Noriyuki |
Director | Award | 45,000 |
| 2022-09-23 | Kamal Fariborz |
President & COO | Award | 15,000 |
| 2022-09-23 | Kasahara Noriyuki |
Director | Other | 0 |
| 2022-12-01 | Bizily Scott |
Chief Legal Officer | Convert | 3,750 |
| 2022-12-01 | Bizily Scott |
Chief Legal Officer | Sell | 100 |
| 2022-12-01 | Bizily Scott |
Chief Legal Officer | Sell | 1,000 |
| 2022-12-01 | Bizily Scott |
Chief Legal Officer | Sell | 375 |
| 2022-12-01 | Bizily Scott |
Chief Legal Officer | Convert | 3,750 |
| 2022-12-01 | Bizily Scott |
Chief Legal Officer | Sell | 2,450 |
| 2022-12-01 | Bizily Scott |
Chief Legal Officer | Sell | 100 |
| 2022-12-01 | Bizily Scott |
Chief Legal Officer | Sell | 400 |
| 2022-12-01 | Bizily Scott |
Chief Legal Officer | Convert | 1,875 |
Showing 51–100 of 328 transactions